ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eftrenonacog Alfa Market Insights, Forecast to 2030
Published Date: November 2024
|
Report Code: QYRE-Auto-39R12373
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Eftrenonacog Alfa Market Research Report 2022
BUY CHAPTERS

Global Eftrenonacog Alfa Market Insights, Forecast to 2030

Code: QYRE-Auto-39R12373
Report
November 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vetter Pharma-Fertigung GmbH & Co. KG
Sanofi Aventis
Biogen
Swedish Orphan Biovitrum AB
Bioverativ Therapeutics Inc.

Eftrenonacog Alfa Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Eftrenonacog Alfa Market

Eftrenonacog Alfa Market

Eftrenonacog alfa is a long-acting recombinant fusion protein used in the treatment of hemophilia B. It is comprised of a single molecule of human factor IX (FIX) covalently linked to the constant region (Fc) domain of human IgG1 via recombinant DNA technology in a human embryonic kidney cell line (HEK293H) 1. The presence of the Fc domain extends the terminal half-life which confers clinical benefits of prolonged therapeutic efficacy, less frequent intravenous injections for patient convenience and improved adherence to prophylaxis.
The global Eftrenonacog Alfa market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Eftrenonacog Alfa, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Eftrenonacog Alfa, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Eftrenonacog Alfa, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Eftrenonacog Alfa sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Eftrenonacog Alfa market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Eftrenonacog Alfa sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Eftrenonacog Alfa Market Report

Report Metric Details
Report Name Eftrenonacog Alfa Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • 250IU
  • 500IU
  • 1000IU
  • 2000IU
Segment by Application
  • Hemophilia
  • Surgical Bleeding
  • Long-term Bleeding Prevention
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioverativ Therapeutics Inc., Biogen Inc, SWEDISH ORPHAN BIOVITRUM AB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Eftrenonacog Alfa in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Eftrenonacog Alfa manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eftrenonacog Alfa sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Eftrenonacog Alfa Market report?

Ans: The main players in the Eftrenonacog Alfa Market are Bioverativ Therapeutics Inc., Biogen Inc, SWEDISH ORPHAN BIOVITRUM AB

What are the Application segmentation covered in the Eftrenonacog Alfa Market report?

Ans: The Applications covered in the Eftrenonacog Alfa Market report are Hemophilia, Surgical Bleeding, Long-term Bleeding Prevention

What are the Type segmentation covered in the Eftrenonacog Alfa Market report?

Ans: The Types covered in the Eftrenonacog Alfa Market report are 250IU, 500IU, 1000IU, 2000IU

1 Study Coverage
1.1 Eftrenonacog Alfa Product Introduction
1.2 Market by Type
1.2.1 Global Eftrenonacog Alfa Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 250IU
1.2.3 500IU
1.2.4 1000IU
1.2.5 2000IU
1.3 Market by Application
1.3.1 Global Eftrenonacog Alfa Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia
1.3.3 Surgical Bleeding
1.3.4 Long-term Bleeding Prevention
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Eftrenonacog Alfa Sales Estimates and Forecasts 2019-2030
2.2 Global Eftrenonacog Alfa Revenue by Region
2.2.1 Global Eftrenonacog Alfa Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Eftrenonacog Alfa Revenue by Region (2019-2024)
2.2.3 Global Eftrenonacog Alfa Revenue by Region (2025-2030)
2.2.4 Global Eftrenonacog Alfa Revenue Market Share by Region (2019-2030)
2.3 Global Eftrenonacog Alfa Sales Estimates and Forecasts 2019-2030
2.4 Global Eftrenonacog Alfa Sales by Region
2.4.1 Global Eftrenonacog Alfa Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Eftrenonacog Alfa Sales by Region (2019-2024)
2.4.3 Global Eftrenonacog Alfa Sales by Region (2025-2030)
2.4.4 Global Eftrenonacog Alfa Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Eftrenonacog Alfa Sales by Manufacturers
3.1.1 Global Eftrenonacog Alfa Sales by Manufacturers (2019-2024)
3.1.2 Global Eftrenonacog Alfa Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Eftrenonacog Alfa in 2023
3.2 Global Eftrenonacog Alfa Revenue by Manufacturers
3.2.1 Global Eftrenonacog Alfa Revenue by Manufacturers (2019-2024)
3.2.2 Global Eftrenonacog Alfa Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Eftrenonacog Alfa Revenue in 2023
3.3 Global Key Players of Eftrenonacog Alfa, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Eftrenonacog Alfa Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Eftrenonacog Alfa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Eftrenonacog Alfa, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Eftrenonacog Alfa, Product Offered and Application
3.8 Global Key Manufacturers of Eftrenonacog Alfa, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Eftrenonacog Alfa Sales by Type
4.1.1 Global Eftrenonacog Alfa Historical Sales by Type (2019-2024)
4.1.2 Global Eftrenonacog Alfa Forecasted Sales by Type (2025-2030)
4.1.3 Global Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
4.2 Global Eftrenonacog Alfa Revenue by Type
4.2.1 Global Eftrenonacog Alfa Historical Revenue by Type (2019-2024)
4.2.2 Global Eftrenonacog Alfa Forecasted Revenue by Type (2025-2030)
4.2.3 Global Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
4.3 Global Eftrenonacog Alfa Price by Type
4.3.1 Global Eftrenonacog Alfa Price by Type (2019-2024)
4.3.2 Global Eftrenonacog Alfa Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Eftrenonacog Alfa Sales by Application
5.1.1 Global Eftrenonacog Alfa Historical Sales by Application (2019-2024)
5.1.2 Global Eftrenonacog Alfa Forecasted Sales by Application (2025-2030)
5.1.3 Global Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
5.2 Global Eftrenonacog Alfa Revenue by Application
5.2.1 Global Eftrenonacog Alfa Historical Revenue by Application (2019-2024)
5.2.2 Global Eftrenonacog Alfa Forecasted Revenue by Application (2025-2030)
5.2.3 Global Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
5.3 Global Eftrenonacog Alfa Price by Application
5.3.1 Global Eftrenonacog Alfa Price by Application (2019-2024)
5.3.2 Global Eftrenonacog Alfa Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Eftrenonacog Alfa Market Size by Type
6.1.1 US & Canada Eftrenonacog Alfa Sales by Type (2019-2030)
6.1.2 US & Canada Eftrenonacog Alfa Revenue by Type (2019-2030)
6.2 US & Canada Eftrenonacog Alfa Market Size by Application
6.2.1 US & Canada Eftrenonacog Alfa Sales by Application (2019-2030)
6.2.2 US & Canada Eftrenonacog Alfa Revenue by Application (2019-2030)
6.3 US & Canada Eftrenonacog Alfa Market Size by Country
6.3.1 US & Canada Eftrenonacog Alfa Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Eftrenonacog Alfa Sales by Country (2019-2030)
6.3.3 US & Canada Eftrenonacog Alfa Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Eftrenonacog Alfa Market Size by Type
7.1.1 Europe Eftrenonacog Alfa Sales by Type (2019-2030)
7.1.2 Europe Eftrenonacog Alfa Revenue by Type (2019-2030)
7.2 Europe Eftrenonacog Alfa Market Size by Application
7.2.1 Europe Eftrenonacog Alfa Sales by Application (2019-2030)
7.2.2 Europe Eftrenonacog Alfa Revenue by Application (2019-2030)
7.3 Europe Eftrenonacog Alfa Market Size by Country
7.3.1 Europe Eftrenonacog Alfa Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Eftrenonacog Alfa Sales by Country (2019-2030)
7.3.3 Europe Eftrenonacog Alfa Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Eftrenonacog Alfa Market Size
8.1.1 China Eftrenonacog Alfa Sales (2019-2030)
8.1.2 China Eftrenonacog Alfa Revenue (2019-2030)
8.2 China Eftrenonacog Alfa Market Size by Application
8.2.1 China Eftrenonacog Alfa Sales by Application (2019-2030)
8.2.2 China Eftrenonacog Alfa Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Eftrenonacog Alfa Market Size by Type
9.1.1 Asia Eftrenonacog Alfa Sales by Type (2019-2030)
9.1.2 Asia Eftrenonacog Alfa Revenue by Type (2019-2030)
9.2 Asia Eftrenonacog Alfa Market Size by Application
9.2.1 Asia Eftrenonacog Alfa Sales by Application (2019-2030)
9.2.2 Asia Eftrenonacog Alfa Revenue by Application (2019-2030)
9.3 Asia Eftrenonacog Alfa Sales by Region
9.3.1 Asia Eftrenonacog Alfa Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Eftrenonacog Alfa Revenue by Region (2019-2030)
9.3.3 Asia Eftrenonacog Alfa Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Eftrenonacog Alfa Market Size by Type
10.1.1 Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Eftrenonacog Alfa Market Size by Application
10.2.1 Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Country
10.3.1 Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Vetter Pharma-Fertigung GmbH & Co.KG
11.1.1 Vetter Pharma-Fertigung GmbH & Co.KG Company Information
11.1.2 Vetter Pharma-Fertigung GmbH & Co.KG Overview
11.1.3 Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Vetter Pharma-Fertigung GmbH & Co.KG Recent Developments
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Company Information
11.2.2 Sanofi Aventis Overview
11.2.3 Sanofi Aventis Eftrenonacog Alfa Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Sanofi Aventis Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Aventis Recent Developments
11.3 Bioverativ Therapeutics Inc.
11.3.1 Bioverativ Therapeutics Inc. Company Information
11.3.2 Bioverativ Therapeutics Inc. Overview
11.3.3 Bioverativ Therapeutics Inc. Eftrenonacog Alfa Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bioverativ Therapeutics Inc. Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bioverativ Therapeutics Inc. Recent Developments
11.4 Biogen Inc
11.4.1 Biogen Inc Company Information
11.4.2 Biogen Inc Overview
11.4.3 Biogen Inc Eftrenonacog Alfa Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Biogen Inc Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biogen Inc Recent Developments
11.5 SWEDISH ORPHAN BIOVITRUM AB
11.5.1 SWEDISH ORPHAN BIOVITRUM AB Company Information
11.5.2 SWEDISH ORPHAN BIOVITRUM AB Overview
11.5.3 SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 SWEDISH ORPHAN BIOVITRUM AB Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Eftrenonacog Alfa Industry Chain Analysis
12.2 Eftrenonacog Alfa Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Eftrenonacog Alfa Production Mode & Process
12.4 Eftrenonacog Alfa Sales and Marketing
12.4.1 Eftrenonacog Alfa Sales Channels
12.4.2 Eftrenonacog Alfa Distributors
12.5 Eftrenonacog Alfa Customers
13 Market Dynamics
13.1 Eftrenonacog Alfa Industry Trends
13.2 Eftrenonacog Alfa Market Drivers
13.3 Eftrenonacog Alfa Market Challenges
13.4 Eftrenonacog Alfa Market Restraints
14 Key Findings in The Global Eftrenonacog Alfa Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Vetter Pharma-Fertigung GmbH & Co. KG
Sanofi Aventis
Biogen
Swedish Orphan Biovitrum AB
Bioverativ Therapeutics Inc.
List of Tables
    Table 1. Global Eftrenonacog Alfa Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 250IU
    Table 3. Major Manufacturers of 500IU
    Table 4. Major Manufacturers of 1000IU
    Table 5. Major Manufacturers of 2000IU
    Table 6. Global Eftrenonacog Alfa Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Eftrenonacog Alfa Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Eftrenonacog Alfa Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Eftrenonacog Alfa Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Eftrenonacog Alfa Revenue Market Share by Region (2019-2024)
    Table 11. Global Eftrenonacog Alfa Revenue Market Share by Region (2025-2030)
    Table 12. Global Eftrenonacog Alfa Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Eftrenonacog Alfa Sales by Region (2019-2024) & (K Units)
    Table 14. Global Eftrenonacog Alfa Sales by Region (2025-2030) & (K Units)
    Table 15. Global Eftrenonacog Alfa Sales Market Share by Region (2019-2024)
    Table 16. Global Eftrenonacog Alfa Sales Market Share by Region (2025-2030)
    Table 17. Global Eftrenonacog Alfa Sales by Manufacturers (2019-2024) & (K Units)
    Table 18. Global Eftrenonacog Alfa Sales Share by Manufacturers (2019-2024)
    Table 19. Global Eftrenonacog Alfa Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Eftrenonacog Alfa Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Eftrenonacog Alfa, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Eftrenonacog Alfa Price by Manufacturers 2019-2024 (US$/Unit)
    Table 23. Global Eftrenonacog Alfa Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Eftrenonacog Alfa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eftrenonacog Alfa as of 2023)
    Table 25. Global Key Manufacturers of Eftrenonacog Alfa, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Eftrenonacog Alfa, Product Offered and Application
    Table 27. Global Key Manufacturers of Eftrenonacog Alfa, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Eftrenonacog Alfa Sales by Type (2019-2024) & (K Units)
    Table 30. Global Eftrenonacog Alfa Sales by Type (2025-2030) & (K Units)
    Table 31. Global Eftrenonacog Alfa Sales Share by Type (2019-2024)
    Table 32. Global Eftrenonacog Alfa Sales Share by Type (2025-2030)
    Table 33. Global Eftrenonacog Alfa Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Eftrenonacog Alfa Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Eftrenonacog Alfa Revenue Share by Type (2019-2024)
    Table 36. Global Eftrenonacog Alfa Revenue Share by Type (2025-2030)
    Table 37. Eftrenonacog Alfa Price by Type (2019-2024) & (US$/Unit)
    Table 38. Global Eftrenonacog Alfa Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 39. Global Eftrenonacog Alfa Sales by Application (2019-2024) & (K Units)
    Table 40. Global Eftrenonacog Alfa Sales by Application (2025-2030) & (K Units)
    Table 41. Global Eftrenonacog Alfa Sales Share by Application (2019-2024)
    Table 42. Global Eftrenonacog Alfa Sales Share by Application (2025-2030)
    Table 43. Global Eftrenonacog Alfa Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Eftrenonacog Alfa Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Eftrenonacog Alfa Revenue Share by Application (2019-2024)
    Table 46. Global Eftrenonacog Alfa Revenue Share by Application (2025-2030)
    Table 47. Eftrenonacog Alfa Price by Application (2019-2024) & (US$/Unit)
    Table 48. Global Eftrenonacog Alfa Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 49. US & Canada Eftrenonacog Alfa Sales by Type (2019-2024) & (K Units)
    Table 50. US & Canada Eftrenonacog Alfa Sales by Type (2025-2030) & (K Units)
    Table 51. US & Canada Eftrenonacog Alfa Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Eftrenonacog Alfa Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Eftrenonacog Alfa Sales by Application (2019-2024) & (K Units)
    Table 54. US & Canada Eftrenonacog Alfa Sales by Application (2025-2030) & (K Units)
    Table 55. US & Canada Eftrenonacog Alfa Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Eftrenonacog Alfa Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Eftrenonacog Alfa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Eftrenonacog Alfa Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Eftrenonacog Alfa Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Eftrenonacog Alfa Sales by Country (2019-2024) & (K Units)
    Table 61. US & Canada Eftrenonacog Alfa Sales by Country (2025-2030) & (K Units)
    Table 62. Europe Eftrenonacog Alfa Sales by Type (2019-2024) & (K Units)
    Table 63. Europe Eftrenonacog Alfa Sales by Type (2025-2030) & (K Units)
    Table 64. Europe Eftrenonacog Alfa Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Eftrenonacog Alfa Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Eftrenonacog Alfa Sales by Application (2019-2024) & (K Units)
    Table 67. Europe Eftrenonacog Alfa Sales by Application (2025-2030) & (K Units)
    Table 68. Europe Eftrenonacog Alfa Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Eftrenonacog Alfa Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Eftrenonacog Alfa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Eftrenonacog Alfa Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Eftrenonacog Alfa Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Eftrenonacog Alfa Sales by Country (2019-2024) & (K Units)
    Table 74. Europe Eftrenonacog Alfa Sales by Country (2025-2030) & (K Units)
    Table 75. China Eftrenonacog Alfa Sales by Type (2019-2024) & (K Units)
    Table 76. China Eftrenonacog Alfa Sales by Type (2025-2030) & (K Units)
    Table 77. China Eftrenonacog Alfa Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Eftrenonacog Alfa Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Eftrenonacog Alfa Sales by Application (2019-2024) & (K Units)
    Table 80. China Eftrenonacog Alfa Sales by Application (2025-2030) & (K Units)
    Table 81. China Eftrenonacog Alfa Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Eftrenonacog Alfa Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Eftrenonacog Alfa Sales by Type (2019-2024) & (K Units)
    Table 84. Asia Eftrenonacog Alfa Sales by Type (2025-2030) & (K Units)
    Table 85. Asia Eftrenonacog Alfa Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Eftrenonacog Alfa Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Eftrenonacog Alfa Sales by Application (2019-2024) & (K Units)
    Table 88. Asia Eftrenonacog Alfa Sales by Application (2025-2030) & (K Units)
    Table 89. Asia Eftrenonacog Alfa Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Eftrenonacog Alfa Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Eftrenonacog Alfa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Eftrenonacog Alfa Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Eftrenonacog Alfa Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Eftrenonacog Alfa Sales by Region (2019-2024) & (K Units)
    Table 95. Asia Eftrenonacog Alfa Sales by Region (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Type (2019-2024) & (K Units)
    Table 97. Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Type (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Application (2019-2024) & (K Units)
    Table 101. Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Application (2025-2030) & (K Units)
    Table 102. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Country (2019-2024) & (K Units)
    Table 108. Middle East, Africa and Latin America Eftrenonacog Alfa Sales by Country (2025-2030) & (K Units)
    Table 109. Vetter Pharma-Fertigung GmbH & Co.KG Company Information
    Table 110. Vetter Pharma-Fertigung GmbH & Co.KG Description and Major Businesses
    Table 111. Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 112. Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Vetter Pharma-Fertigung GmbH & Co.KG Recent Developments
    Table 114. Sanofi Aventis Company Information
    Table 115. Sanofi Aventis Description and Major Businesses
    Table 116. Sanofi Aventis Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 117. Sanofi Aventis Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Sanofi Aventis Recent Developments
    Table 119. Bioverativ Therapeutics Inc. Company Information
    Table 120. Bioverativ Therapeutics Inc. Description and Major Businesses
    Table 121. Bioverativ Therapeutics Inc. Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 122. Bioverativ Therapeutics Inc. Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Bioverativ Therapeutics Inc. Recent Developments
    Table 124. Biogen Inc Company Information
    Table 125. Biogen Inc Description and Major Businesses
    Table 126. Biogen Inc Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 127. Biogen Inc Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Biogen Inc Recent Developments
    Table 129. SWEDISH ORPHAN BIOVITRUM AB Company Information
    Table 130. SWEDISH ORPHAN BIOVITRUM AB Description and Major Businesses
    Table 131. SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 132. SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. SWEDISH ORPHAN BIOVITRUM AB Recent Developments
    Table 134. Key Raw Materials Lists
    Table 135. Raw Materials Key Suppliers Lists
    Table 136. Eftrenonacog Alfa Distributors List
    Table 137. Eftrenonacog Alfa Customers List
    Table 138. Eftrenonacog Alfa Market Trends
    Table 139. Eftrenonacog Alfa Market Drivers
    Table 140. Eftrenonacog Alfa Market Challenges
    Table 141. Eftrenonacog Alfa Market Restraints
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Eftrenonacog Alfa Product Picture
    Figure 2. Global Eftrenonacog Alfa Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Eftrenonacog Alfa Market Share by Type in 2023 & 2030
    Figure 4. 250IU Product Picture
    Figure 5. 500IU Product Picture
    Figure 6. 1000IU Product Picture
    Figure 7. 2000IU Product Picture
    Figure 8. Global Eftrenonacog Alfa Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Eftrenonacog Alfa Market Share by Application in 2023 & 2030
    Figure 10. Hemophilia
    Figure 11. Surgical Bleeding
    Figure 12. Long-term Bleeding Prevention
    Figure 13. Eftrenonacog Alfa Report Years Considered
    Figure 14. Global Eftrenonacog Alfa Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Eftrenonacog Alfa Revenue 2019-2030 (US$ Million)
    Figure 16. Global Eftrenonacog Alfa Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Eftrenonacog Alfa Revenue Market Share by Region (2019-2030)
    Figure 18. Global Eftrenonacog Alfa Sales 2019-2030 ((K Units)
    Figure 19. Global Eftrenonacog Alfa Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Eftrenonacog Alfa Sales YoY (2019-2030) & (K Units)
    Figure 21. US & Canada Eftrenonacog Alfa Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Eftrenonacog Alfa Sales YoY (2019-2030) & (K Units)
    Figure 23. Europe Eftrenonacog Alfa Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Eftrenonacog Alfa Sales YoY (2019-2030) & (K Units)
    Figure 25. China Eftrenonacog Alfa Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Eftrenonacog Alfa Sales YoY (2019-2030) & (K Units)
    Figure 27. Asia (excluding China) Eftrenonacog Alfa Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Eftrenonacog Alfa Sales YoY (2019-2030) & (K Units)
    Figure 29. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Eftrenonacog Alfa Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Eftrenonacog Alfa in the World: Market Share by Eftrenonacog Alfa Revenue in 2023
    Figure 32. Global Eftrenonacog Alfa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
    Figure 34. Global Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
    Figure 35. Global Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
    Figure 36. Global Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Eftrenonacog Alfa Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Eftrenonacog Alfa Sales Share by Country (2019-2030)
    Figure 43. U.S. Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
    Figure 46. Europe Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
    Figure 48. Europe Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Eftrenonacog Alfa Revenue Share by Country (2019-2030)
    Figure 50. Europe Eftrenonacog Alfa Sales Share by Country (2019-2030)
    Figure 51. Germany Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 52. France Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 56. China Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
    Figure 57. China Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
    Figure 58. China Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
    Figure 59. China Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
    Figure 61. Asia Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
    Figure 63. Asia Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Eftrenonacog Alfa Revenue Share by Region (2019-2030)
    Figure 65. Asia Eftrenonacog Alfa Sales Share by Region (2019-2030)
    Figure 66. Japan Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 70. India Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Eftrenonacog Alfa Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Eftrenonacog Alfa Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Eftrenonacog Alfa Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Eftrenonacog Alfa Sales Share by Country (2019-2030)
    Figure 77. Brazil Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Eftrenonacog Alfa Revenue (2019-2030) & (US$ Million)
    Figure 82. Eftrenonacog Alfa Value Chain
    Figure 83. Eftrenonacog Alfa Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Metronidazole API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18R12687
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Human Antihistamine Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32E7162
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Low Dead Volume Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-15K8807
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Cancer Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0Q10604
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions